← Back to Search

Umbilical Cord Milking for Non-Vigorous Infants (MINVIFU Trial)

N/A

Waitlist Available

Led By Anup Katheria, MD

Research Sponsored by Sharp HealthCare

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 22-26 months

Awards & highlights

MINVIFU Trial Summary

This trial will compare neurodevelopmental outcomes of term/near-term infants who received UCM or ECC.

Eligible Conditions

Neurodevelopmental Disorder

MINVIFU Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 22-26 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~22-26 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 22-26 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Neurodevelopmental Outcome at 2 Years of Age

Secondary outcome measures

Autism Outcome

MINVIFU Trial Design

2Treatment groups

Active Control

Group I: Early Cord ClampingActive Control1 Intervention

The umbilical cord is clamped within 30 seconds of delivery.

Group II: Umbilical Cord MilkingActive Control1 Intervention

At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 15-20 seconds.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Sharp HealthCareLead Sponsor

40 Previous Clinical Trials

15,937 Total Patients Enrolled

Anup Katheria, MD3.02 ReviewsPrincipal Investigator - Neonatologist

Sharp HealthCare

15 Previous Clinical Trials

11,843 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who qualifies to participate in this research trial?

"For this investigation, 1207 infants aged 22 to 36 months with fetal anomalies must be admitted. Participants should also have been previously enrolled in the MINVI trial and survived until two years old when corrected for prematurity."

Answered by AI

What is the prevalence of this clinical trial within the state's hospital network?

"The current recruitment phase of this experiment encompasses a total of 9 sites, including Davis, Salt Lake City and Portland. To reduce any travel burden on participants, it is highly recommended to select the clinic closest in proximity when signing up for the trial."

Answered by AI

Are juveniles eligible to participate in this scientific exploration?

"This clinical trial is only for young people between the ages of 22 and 26 months. Meanwhile, there are 51 different studies available to participants under 18 years old and 78 geared towards those over 65."

Answered by AI

Are people currently able to participate in this study?

"This clinical trial is not presently recruiting patients. Initially posted on the 7th of January 2019, and most recently edited on 22nd June 2022, this study does not currently require any further participants. Although there are 116 medical studies open for recruitment at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU)

Anup Katheria, M.D. 2019. "Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03621943.